DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Death (226)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 226   Next >>

Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death, Chalazion

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-08-13
    End date: 2012-01-03

Other drugs received by patient: Bisphosphonates; Travoprost



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Soft Tissue Neoplasm

Trabectedin
    Dosage: 1500 microgram per sq meter, q3w
    Indication: Soft Tissue Neoplasm



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Dexamethasone side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13

Patient:

Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma

Thalidomide
    Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib



Possible Dexamethasone side effects in

Reported by a physician from Turkey on 2012-08-10

Patient:

Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1 mg, / day

Bortezomib
    Dosage: 1.3 mg/m2 days:1,4,8,11
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Hydroxyurea
    Dosage: unk, unknown
    Indication: Essential Thrombocythaemia
    Start date: 2000-09-01

Thalidomide
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Other drugs received by patient: Thyroid Replacement Therapy



Possible Dexamethasone side effects in

Reported by a physician from Turkey on 2012-08-10

Patient:

Reactions: Death, Peripheral Sensorimotor Neuropathy, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1 mg, / day

Bortezomib
    Dosage: 1.3 mg/m2 days:1,4,8,11
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Hydroxyurea
    Dosage: unk, unknown
    Indication: Essential Thrombocythaemia
    Start date: 2000-09-01

Thalidomide
    Dosage: unk, unknown
    Indication: Multiple Myeloma

Other drugs received by patient: Thyroid Replacement Therapy



Possible Dexamethasone side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Dysphagia, Incorrect Dose Administered, Anaemia, Rash, Eating Disorder, Death, Decubitus Ulcer, Oral Candidiasis, Dyspepsia, Gastrooesophageal Reflux Disease, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Start date: 2012-05-12

Erlotinib Hydrochloride
    Dosage: 25 mg, uid/qd
    Administration route: Oral
    Start date: 2012-05-07

Erlotinib Hydrochloride
    Dosage: 50 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-04-30

Other drugs received by patient: Keppra; Chemotherapy; Steroid



Possible Dexamethasone side effects in male

Reported by a physician from Canada on 2012-08-09

Patient: male, weighing 84.5 kg (185.9 pounds)

Reactions: Death, Sinusitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 5.7143 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-10-27

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-10-27

Other drugs received by patient: Tylenol W / Codeine; Tinzaparin; Calcium; Benadryl; Colace; Eprex; Aspirin; Allertin; Vitamin D; Eprex; Curamin; Vitamin B Complex CAP; Ascorbic Acid; Codeine Phosphate and Acetaminophen



Possible Dexamethasone side effects in

Reported by a physician from Israel on 2012-08-08

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-08-03

Patient:

Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Bortezomib
    Dosage: .7 milligram/sq. meter

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: male

Reactions: Back Pain, Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 1620 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-09-08
    End date: 2011-09-08

Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-09-08
    End date: 2011-10-13

Velcade
    Dosage: 2 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-09-08
    End date: 2011-10-05



Possible Dexamethasone side effects in male

Reported by a physician from Australia on 2012-08-02

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24

Other drugs received by patient: Docusate Senna; Oxycontin; Lactulose; Valaciclovir; Amlodipine



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: female

Reactions: Malnutrition, Hyperglycaemia, Fall, Hepatic Enzyme Increased, Death, Oral Candidiasis, Oedema Peripheral, Urosepsis, Pulmonary Oedema, Asthenia, Acute Respiratory Failure, Escherichia Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg, bid
    Indication: Metastases To Central Nervous System
    Start date: 2012-05-02

Dexamethasone
    Dosage: unk

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2012-05-31

Other drugs received by patient: Duragesic-100; Folic Acid; Xanax; Celexa; Clarinex / 01202601 /; Advair; Keppra; Pepcid; Provera; Estrace; Flexeril; Vicodin; Compazine



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Spain on 2012-07-30

Patient:

Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200mg daily (escalating doses in the first cycle)
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-27

Patient:

Reactions: Death, Adrenal Carcinoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Acyclovir



Possible Dexamethasone side effects in male

Reported by a physician from Australia on 2012-07-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24

Other drugs received by patient: Valaciclovir; Lactulose; Oxycontin; Amlodipine; Docusate Senna



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-07-18

Patient:

Reactions: Death, Lung Infection, Myocardial Infarction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 75 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    End date: 2012-02-07

Other drugs received by patient: Bisoprolol Fumarate; Clopidogrel; Ezetimibe; Perindopril Erbumine; Lercanidipine; Plavix; Acetaminophen; Codeine Phosphate and Acetaminophen



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16

Patient:

Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 15 milligram/sq. meter

Adriamycin PFS
    Dosage: 9 milligram/sq. meter
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: 1000 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 200 milligram/sq. meter

Thalomid
    Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
    Administration route: Oral
    Indication: Multiple Myeloma

Thalomid
    Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
    Administration route: Oral

Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Dexamethasone side effects in male

Reported by a physician from Spain on 2012-07-13

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-13
    End date: 2012-04-09

Dexamethasone
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-05-07

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-13
    End date: 2012-04-02

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-05-07

Other drugs received by patient: Aspirin; Cefixim; Cefepim



Possible Dexamethasone side effects in male

Reported by a physician from Australia on 2012-07-12

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-24



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017